AI assistant
Sending…
MACROGENICS INC — Director's Dealing 2020
Feb 6, 2020
34129_dirs_2020-02-06_c8287643-9885-4a4c-819f-55d425f4e1e3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MACROGENICS INC (MGNX)
CIK: 0001125345
Period of Report: 2020-02-04
Reporting Person: Risser Eric Blasius (Sr VP & Chief Business Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-02-04 | Common Stock | M | 30 | $0.94 | Acquired | 32498 | Direct |
| 2020-02-04 | Common Stock | S | 30 | $10 | Disposed | 32468 | Direct |
| 2020-02-05 | Common Stock | M | 623 | $0.94 | Acquired | 33091 | Direct |
| 2020-02-05 | Common Stock | S | 623 | $10 | Disposed | 32468 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-02-04 | Employee stock option (right to buy) | $0.94 | M | 30 | Disposed | 2022-03-13 | Common Stock (30.0) | Direct |
| 2020-02-05 | Employee stock option (right to buy) | $0.94 | M | 623 | Disposed | 2022-03-13 | Common Stock (623.0) | Direct |
Footnotes
F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 5, 2019.
More from MACROGENICS INC
Declaration of Voting Results & Voting Rights Announcements
2026
May 20
Regulatory Filings
2026
May 13
Merger & Acquisition
2026
May 12
Proxy Solicitation & Information Statement
2026
Apr 8
Major Shareholding Notification
2026
Mar 27
Board/Management Information
2026
Mar 2
Regulatory Filings
2026
Feb 24
Director's Dealing
2026
Feb 18
Director's Dealing
2026
Feb 18
Director's Dealing
2026
Feb 18